2014-December-04 2014;5(257):257
Nonfatal myocardial infarction occurred in 2.3% of patients treated with oral semaglutide and 1.9% treated with placebo (HR 1.18, 95% CI 0.731.90), nonfatal stroke occurred in 0.8% versus 1.0% treated with placebo (HR 0.74, 95% CI 0.351.57), and death from cardiovascular causes occurred in 0.9% versus 1.9% treated with placebo (HR 0.51, 95% CI 0.310.84)
Data are presented as mean values
Food does not interfere with semaglutide's effectiveness because the injection delivers the medication directly into your bloodstream, not through your digestive system
A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
Blood Sugar Balance: Blood sugar spikes can create oxidative stress and glycation, which are linked to pigmentation, especially hormonal melasma